Horan Securities’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$972K Buy
40,092
+29
+0.1% +$701 0.34% 35
2025
Q1
$970K Sell
40,063
-316
-0.8% -$7.63K 0.37% 28
2024
Q4
$972K Sell
40,379
-2,943
-7% -$71K 0.37% 25
2024
Q3
$1.05M Sell
43,322
-2,106
-5% -$50.7K 0.41% 21
2024
Q2
$1.08M Buy
45,428
+5,995
+15% +$142K 0.47% 14
2024
Q1
$940K Buy
39,433
+4,058
+11% +$96.7K 0.44% 20
2023
Q4
$845K Buy
35,375
+692
+2% +$16.2K 0.43% 20
2023
Q3
$809K Buy
34,683
+5,720
+20% +$134K 0.43% 20
2023
Q2
$680K Buy
28,963
+1,034
+4% +$24.4K 0.29% 38
2023
Q1
$663K Buy
27,929
+24,447
+702% +$575K 0.34% 26
2022
Q4
$81.3K Buy
+3,482
New +$80.8K 0.05% 158

Other funds holding IBDR

Horan Securities's IBDR Position: Q2 2025 in Review

Horan Securities increased its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 0.07% in Q2 2025, buying an estimated $701 and bringing the position to 40,092 shares worth $972K. The position accounts for 0.34% of the portfolio, ranked #35.

Horan Securities first reported a position in IBDR in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.08M in Q2 2024. 409 funds tracked by Wall St. Rank hold IBDR as of Q2 2025.

  • Horan Securities held 40,092 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $972K as of Q2 2025.
  • Horan Securities bought 29 iShares iBonds Dec 2026 Term Corporate ETF shares in Q2 2025, an estimated $701.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.34% of Horan Securities's portfolio in Q2 2025, its #35 holding.
  • Horan Securities first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q4 2022 and has held it in 11 quarters since.
  • Horan Securities's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $1.08M in Q2 2024.
  • 409 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2025.

Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.